Want to join the conversation?
Biotechnology company $AMGN announced detailed phase 2 results of erenumab drug that showed a significant reduction in monthly migraine days compared with placebo in patients with chronic migraine. This data will be presented at the 5th European Headache and Migraine Trust International Congress (EHMTIC) in Glasgow, Scotland.
I haven’t seen a drop in banks like this in a long time. Looks like $WFC is still facing pressures from its sales practices scandal..!!
Helping President-elect's America first focus, $WMT set to create 10,000 retail jobs in the US in 2017.
Looks like Trump has his eyes on the $MON and Bayer merger next. He had a meeting with the CEOs and apparently got job promises from them.